Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) announced clinical data on adipose tissue distribution in non-diabetic patients treated with sotagliflozin will be presented at the 22nd Global Cardio ...
In its latest PFDD installment, the FDA offers a detailed roadmap for sponsors seeking to design, adapt, or validate COAs that accurately ...
GTA182 demonstrates favorable safety, dose-proportional pharmacokinetics, robust PRMT5 pathway inhibition, and encouraging ...
Clene is planning to submit an application to the FDA in early 2026 requesting the accelerated approval of CNM-Au8 for ALS.
The U.S. Food and Drug Administration approved an Investigational New Drug (IND) application using efficacy data solely from ...
The launch of a new accessible membership tier and a 47-state clinical expansion strengthen Geviti’s infrastructure for ...
The cancer center’s first test of the technology matched all of its manually identified clinical trials candidates and found ...
A new working paper has found that one-third of all data points collected in 105 phase 2 and 3 trials were not needed for the studies’ key analyses, while also highlighting how an increase in clinical ...
Digit health technologies (DHT) are a key aspect of U.S. Health & Human Services (HHS) Secretary Robert F. Kennedy Jr.’s Make America Healthy ...
AWS also introduced the Trainium 3 chip and new AI-optimised servers designed to handle resource-intensive healthcare ...
The technology is designed to help thousands of diabetic and hypertensive patients achieve control over their conditions, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback